The COVID-19 disease due to infection by the SARS-CoV2 virus has changed the behavior patterns of humanity by becoming a pandemic of international scope. To date, more than 136 million people have suffered from the disease and more than 2.9 million of them have lost their lives. It is important to remember that the symptoms […]

The epigenetics and immune diseases group of the Josep Carreras Leukaemia research Institute, led by Dr Esteban Ballestar. In May, the epigenetics and immune diseases group of the Josep Carreras Leukaemia Research Institute, led by Dr Esteban Ballestar, together with Roser Vento-Tormo (Sanger Institute, United Kingdom), obtained one of the five worldwide grants awarded by […]

►Head of the Carreras Leukemia Center at Marburg University Hospital and vice-president of the José Carreras Leukämie Stiftung, Professor Dr. Andreas Neubauer, plans scientific study on the use of an immune inhibitor against this viral disease. Professor Dr. Andreas Neubauer and his team from the Marburg University Medical center is raising hope for a COVID-19 […]

Los conocimientos que acumulan la Fundación y el Instituto Josep Carreras sobre las células de la sangre y el sistema inmunitario son muy útiles para luchar contra la pandemia ► Los pacientes con leucemias, linfomas y mielomas, enfermedades que directamente alteran el correcto funcionamiento del sistema inmune, son una población extremadamente vulnerable a COVID-19 desde […]

At the Josep Carreras Leukaemia Foundation we believe it is useful and necessary to provide you with information regarding the precautionary measures that should be taken by people who are suffering from, or who have suffered from, leukaemia, lymphomas, multiple myeloma or any other malignant blood disease. Patients CURRENTLY suffering from cancer are HIGH RISK […]